期刊文献+

不同性别人群的蛋白质N-糖基结构谱型比较

Comparison of structure profiles of protein N-glycosylation between two genders
原文传递
导出
摘要 目的对不同性别人群的血浆N-糖基结构谱型进行分析比较,为基础人群N-糖基结构的分布提供科学依据。方法采用整群抽样,以2009年4~7月在北京某社区调查的212名居民为研究对象,基于高效液相色谱法进行血浆糖基组检测。不同性别的糖基含量比较采用两独立样本t检验或非参检验,P〈0.05为差异有统计学意义。结果 212名研究对象的平均年龄为(37.78±17.89)岁,性别比为0.88。半乳糖基化修饰水平,男性双触角非半乳糖聚糖水平略高(Z=2.33,P=0.02),女性单半乳糖聚糖水平较高(t=-2.06,P=0.04)。岩藻糖基化分析显示,女性核心岩藻糖化聚糖水平略高(t=-2.16,P=0.03)。唾液酸糖基化水平中,女性单唾液酸糖基化水平较高(t=-2.43,P=0.02),男性二唾液酸糖基化水平较高(t=2.11,P=0.04)。结论血浆N-糖基结构水平可能存在性别决定性。 Objective To analyze and compare the structure profiles of plasma N-glycosylation between two genders in order to provide scientific basis for the distribution of N-glycosylation. Methods A cluster sampling method was used to randomly select 212 residents from a community in Beijing.Blood samples were collected and plasma N-glycans were identified by high performance liquid chromatography(HPLC). ResultsThe average age of subjects was 37.78±17.89 years with the sex ratio of 0.88.The levels of galactosylation,fucosylation and Sialic glycosylation of N-glycans were all significantly different between male and female subjects(P〈0.05),with more monogalactosylated glycans,core-fucosylated glycans and monosialo in women,and more biantennary non-galactosylated glycans and disialo in men. Conclusions The plasma N-glycome profile is gender dependent,therefore,it is very important to consider this difference when the glycome markers are to be developed.
出处 《中国预防医学杂志》 CAS 2014年第6期566-570,共5页 Chinese Preventive Medicine
基金 国家自然科学基金项目(81373099) 国家自然科学基金项目(81001281) 北京市自然科学基金资助项目(7131002)
关键词 蛋白质N-糖基化修饰 性别 高效液相色谱 Protein N-glycosylation Gender HPLC
  • 相关文献

参考文献14

  • 1Arnold JN, Wormald MR, Sire RB, eta1. The impact of glycosylation on the biological function and structure of hu- man immunoglobulins[J]. Annu Rev Immunol, 2007, 25: 21-50.
  • 2Parodi AJ. Reglucosylation of glycoproteins and quality con- trol of glycoprotein folding in the endoplasmic reticulum of yeast cells [J]. Biochim Biophys Acta, 1999, 1426 (2) : 287-295.
  • 3Litynska A, Przybylo M, Poehec E, et al. Comparison of the lectin-binding pattern in different human melanoma cell lines [J] Melanoma Res, 2001, 11 (3) : 205-212.
  • 4Krishnan V, Bane SM, Kawle PD, et al. Altered melano- ma cell surface glycosylation mediates organ specific adhe- sion and metastasis via lectin receptors on the lung vascular endothelium [J]. Clin Exp Metastasis, 2005, 22 (1) : 11 24.
  • 5Knezevie A, Gornik O, Polasek O, et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on hu- man plasma N-glycans [J]. Glycobiology, 2010, 20 (8).- 959-969.
  • 6Zhao YP, Ruan CP, Wang H, et al. Identification and as sessment of new biomarkers for colorectal cancer with serum N-glycan profiling [J]. Cancer, 2012, 118 (3): 639,650.
  • 7Saeland E, Belo AI, Mongera S, et al. Differential glyco- sylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients [J]. Int J Cancer, 2012, 131 (1): 117-128.
  • 8Saldova R, Reuben JM, Abd Harold UM, et al. Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts [J]. Ann Oncol, 2011, 22 (5): 1113-1119.
  • 9Saldova R, Fan Y, Fitzpatrick JM, etal. Core fucosyla- tion and alpha2-3 sialylation in serum N-glycome is signifi- cantly increased in prostate cancer comparing to benign pros- tate hyperplasia [J]. Glyeobiology, 2011, 21 (2): 195- 205.
  • 10Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer hiomarkers [J]. Clin Proteomies, 2011, 8 (1), 7.

二级参考文献18

  • 1Wang Y,Wu SL,Hancock WS.Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap-Fourier transform mass spectrometry[J].Glycobiology,2006,16(6):514-523.
  • 2Lau KS,Partridge EA,Grigorian A,et al.Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation[J].Cell,2007,129(1):123-134.
  • 3Rudd PM,Elliott T,Cresswell P,et al.Glycosylation and the immune system[J].Science,2001,291:2370-2376.
  • 4Xu J,Ge X,Dolan MC.Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures[J].Biotechnol Adv,2011,29(3):278-299.
  • 5Kanda Y,Yamada T,Mori K,et al.Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides:the high-mannose,hybrid,and complex types[J].Glycobiology,2007,17(1):104-118.
  • 6Alessandri L,Ouellette D,Acquah A,et al.Increased serum clearance of oligomannose species present on a human IgG1 molecule[J].MAbs,2012,4(4):509-520.
  • 7Grattendick KJ,Nakashima JM,Feng L,et al.Effects of three anti-TNF-α drugs:etanercept,infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro[J].Int Immunopharmacol,2008,8(5):679-687.
  • 8Payne T.Biosimilar draft guidance issue by US FDA[J].Bioanalysis,2012,4(7):759-761.
  • 9Liu LM,Gomathinayagam S,Hamuro L,et al.The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris[J].Pharm Res,2013,30:803-812.
  • 10Tan QQ,Guo QC,Fang C,et al.Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products[J].MAbs,2012,4(6):761-774.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部